---
schema_version: "secwatch.filing_event.v1"
accession: "0001818382-25-000061"
form_type: "8-K"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2025-04-18T23:59:59+00:00"
generated_at: "2026-05-23T11:08:09.412663+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Humacyte CEO: citizen petition is baseless; signatories have conflicts of interest

## Summary
- CEO Laura Niklason says petition signed by Robert E. Lee and Hooman Noorchashm is 'without merit'.
- States Lee left FDA last fall and now heads Echelon, which advises Phraxis, a competitor.
- Notes Noorchashm has filed nine prior FDA petitions with no resulting agency action.
- Company will respond to the FDA at the appropriate time, calling claims 'false and harmful'.

## SEC filing metadata
- accession: 0001818382-25-000061
- form_type: 8-K
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2025-04-18T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000181838225000061/0001818382-25-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000181838225000061/huma-20250417.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818382-25-000061
- JSON: https://secwatch.observer/filing/0001818382-25-000061.json
- Plain text: https://secwatch.observer/filing/0001818382-25-000061.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.